GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » Revenue per Share

Gubra AS (CHIX:GUBRAC) Revenue per Share : kr16.36 (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Revenue per Share?

Gubra AS's revenue per share for the six months ended in Dec. 2024 was kr9.17. Gubra AS's revenue per share for the trailing twelve months (TTM) ended in Dec. 2024 was kr16.36.

During the past 12 months, the average Revenue Per Share Growth Rate of Gubra AS was 20.60% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 1.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Gubra AS's Revenue per Share or its related term are showing as below:

CHIX:GUBRAc' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 1.4   Med: 5   Max: 8.6
Current: 1.4

During the past 6 years, Gubra AS's highest 3-Year average Revenue Per Share Growth Rate was 8.60% per year. The lowest was 1.40% per year. And the median was 5.00% per year.

CHIX:GUBRAc's 3-Year Revenue Growth Rate is ranked worse than
50.83% of 781 companies
in the Biotechnology industry
Industry Median: 2.2 vs CHIX:GUBRAc: 1.40

Gubra AS Revenue per Share Historical Data

The historical data trend for Gubra AS's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Revenue per Share Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Revenue per Share
Get a 7-Day Free Trial 10.54 15.62 12.20 13.51 16.30

Gubra AS Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Revenue per Share Get a 7-Day Free Trial Premium Member Only 6.22 7.30 6.30 7.19 9.17

Competitive Comparison of Gubra AS's Revenue per Share

For the Biotechnology subindustry, Gubra AS's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gubra AS's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's PS Ratio distribution charts can be found below:

* The bar in red indicates where Gubra AS's PS Ratio falls into.


;
;

Gubra AS Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Gubra AS's Revenue Per Share for the fiscal year that ended in Dec. 2024 is calculated as

Revenue Per Share (A: Dec. 2024 )=Revenue (A: Dec. 2024 )/Shares Outstanding (Diluted Average) (A: Dec. 2024 )
=265.741/16.304
=16.30

Gubra AS's Revenue Per Share for the quarter that ended in Dec. 2024 is calculated as

Revenue Per Share (Q: Dec. 2024 )=Revenue (Q: Dec. 2024 )/Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
=145.114/15.823
=9.17

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr16.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gubra AS  (CHIX:GUBRAc) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Gubra AS Revenue per Share Related Terms

Thank you for viewing the detailed overview of Gubra AS's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS Business Description

Traded in Other Exchanges
Address
Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has three segments: Pre-clinical contract research (CRO), which derives maximum revenue; Discovery & Partnerships (D&P) Segment; and Gubra Green Segment.

Gubra AS Headlines

No Headlines